Asia-Pacific Point-of-Care Testing (POCT) Market – Industry Trends and Forecast to 2027

  • Healthcare IT
  • Upcoming Report
  • Jun 2020
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Asia-Pacific Point-of-Care Testing (POCT) Market, By Product (Blood Glucose Testing Kits, Cardiometabolic Monitoring Kits, Infectious Disease Testing Kits, Cholesterol Testing Kits, Pregnancy & Fertility Tests Kits, Tumor/Cancer Markers, Urinalysis Testing Kits, Cholesterol Test Strips, Hematology Testing Kits, Drugs of Abuse Testing Kits, Fecal Occult Testing Kits, Rapid Coagulation Testing Kits, Others), Prescription Mode (Prescription, Over The Counter), Distribution Channel (Direct Tenders, Retail), End User (Hospital, Clinics, Ambulatory Care, Home Healthcare, Research Laboratory), Country (Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific) Industry Trends and Forecast to 2027

Asia-Pacific Point-of-Care Testing (POCT) Market

Market Analysis and Insights: Asia-Pacific Point-of-Care Testing (POCT) Market

Point-of-care testing (POCT) market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 12.53 billion by 2027 growing at a CAGR of 10.35% in the above-mentioned forecast period. The growing prevalence of infectious diseases in developing countries will help in driving the growth of the point-of-care testing (POCT) market.

Growing scenarios of target conditions, rising government support, shortages of skilled laboratory technicians, rising number of CLIA-waived POC tests will likely to accelerate the growth of the point-of-care testing (POCT) market in the forecast period of 2020-2027. On the other hand, rising awareness through conferences and events along with growing market will further boost various opportunities that will lead to the growth of the point-of-care testing (POCT) market in the above mentioned forecast period.

High costs of POCT device and low rate of reimbursement scenario will likely to hamper the growth of the point-of-care testing (POCT) market in the above mentioned forecast period. The shortage of alignment within definitive central lab methods is going to be a challenge for the point-of-care testing (POCT) market.

This point-of-care testing (POCT) market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographical expansions, technological innovations in the market. To gain more info on point-of-care testing (POCT) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Asia-Pacific Point-of-Care Testing (POCT) Market Scope and Market Size

Point-of-care testing (POCT) market is segmented on the basis of product, prescription mode, distribution channel and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • Based on product, the point-of-care testing (POCT) market is segmented into blood glucose testing kits, cardiometabolic monitoring kits, infectious disease testing kits, cholesterol testing kits, pregnancy & fertility tests kits, tumor/cancer markers, urinalysis testing kits, cholesterol test strips, hematology testing kits, drugs of abuse testing kits, fecal occult testing kits, rapid coagulation testing kits and others.
  • Based on prescription mode, the point-of-care testing (POCT) market is segmented into prescription and over the counter.
  • On the basis of distribution channel, the point-of-care testing (POCT) market is segmented into direct tenders and retail.
  • Point-of-care testing (POCT) market has also been segmented based on the end user into hospital, clinics, ambulatory care, home healthcare and research laboratory.

Point-of-Care Testing (POCT) Market Country Level Analysis

Point-of-care testing (POCT) market is analysed and market size insights and trends are provided by country, product, prescription mode, distribution channel and end user as referenced above.

The countries covered in the point-of-care testing (POCT) market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, and rest of Asia-Pacific (APAC).

Asia-Pacific is expected to grow at the highest growth rate with China emerging as a leader in the forecast period of 2020 to 2027 due to growing number of new hospital construction projects and thus boosting the demand for medical and surgical equipment.

The country section of the point-of-care testing (POCT) market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Point-of-care testing (POCT) Market Share Analysis

Point-of-care testing (POCT) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to point-of-care testing (POCT) market.

The major players covered in the point-of-care testing (POCT) market report are Abbott, Alere Inc., Siemens, BD, Johnson & Johnson Services Inc., PTS Diagnostics, Instrumentation Laboratory, Nova Biomedical, Beckman Coulter, Inc., Werfen among other domestic players. Market share data is available for Asia-Pacific (APAC) separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Customization Available: Asia-Pacific Point-of-Care Testing (POCT) Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

LIST OF TABLE APAC Point-Of-Care Testing Market

TABLE 1 LIST OF DIFFERENT TYPES OF APPROVAL FOR DIFFERENT COUNTRIES TABLE 2 APAC POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 3 APAC CARDIOMETABOLIC MONITORING POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 4 APAC INFECTIOUS DISEASE POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 5 APAC CHOLESTEROL POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 6 APAC POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 7 APAC POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 8 DISTRIBUTION CHANNEL, RETAIL PHARMACY, BY COUNTRIES 2015 – 2024 (USD MILLION) TABLE 9 APAC POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 10 APAC POINT-OF-CARE TESTING MARKET, HOSPITALS, BY COUNTRIES 2015– 2024 (USD MILLION) TABLE 11 APAC POINT-OF-CARE TESTING MARKET, CLINICS, BY COUNTRY 2015– 2024 (USD MILLION) TABLE 12 APACPOINT-OF-CARE TESTING MARKET, AMBULATORY CARE, BY COUNTRY 2015– 2024 (USD MILLION) TABLE 13 APAC POINT-OF-CARE TESTING MARKET, HOME HEALTHCARE, BY COUNTRY 2015– 2024 (USD MILLION) TABLE 14 APAC POINT-OF-CARE TESTING MARKET, RESEARCH LABORATORY, BY COUNTRY 2015– 2024 (USD MILLION) TABLE 15 APAC POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015– 2024 (USD MILLION) TABLE 16 APAC POINT-OF-CARE TESTING MARKET, PRESCRIPTION BASED TESTING KITS, BY COUNTRY, 2015– 2024 (USD MILLION) TABLE 17 APAC POINT-OF-CARE TESTING MARKET, OVER THE COUNTER BASED TESTING KITS, BY COUNTRY, 2015– 2024 (USD MILLION) TABLE 18 APAC POINT-OF-CARE TESTING MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 19 APAC POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 20 APAC CARDIOMETABOLIC MONITORING POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 21 APAC INFECTIOUS DISEASE POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 22 APAC CHOLESTEROL POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 23 APAC POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 24 APAC POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 25 APAC POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL , 2015– 2024 (USD MILLION) TABLE 26 JAPAN POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 27 JAPAN POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 28 JAPAN POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 29 JAPAN POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION) TABLE 30 CHINA POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 31 CHINA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 32 CHINA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 33 CHINA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION) TABLE 34 SOUTH KOREA POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 35 SOUTH KOREA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024(USD MILLION) TABLE 36 SOUTH KOREA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 37 SOUTH KOREA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION) TABLE 38 INDIA POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION) TABLE 39 INDIA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 40 INDIA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 41 INDIA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL , 2015– 2024 (USD MILLION) TABLE 42 AUSTRALIA POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 43 AUSTRALIA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 44 AUSTRALIA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 45 AUSTRALIA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION) TABLE 46 SINGAPORE POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 47 SINGAPORE POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 48 SINGAPORE POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 49 SINGAPORE POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION) TABLE 50 THAILAND POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 51 THAILAND POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 52 THAILAND POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 53 THAILAND POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION) TABLE 54 MALAYSIA POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 55 MALAYSIA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 56 MALAYSIA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 57 MALAYSIA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION) TABLE 58 INDONESIA POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 59 INDONESIA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 60 INDONESIA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 61 INDONESIA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION) TABLE 62 PHILIPPINES POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 63 PHILIPPINES POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 64 PHILIPPINES POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 65 PHILIPPINES POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION) TABLE 66 REST OF APAC POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
BUY NOW ADD TO CART
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19